Sector: MedicalRHHBY (OTCBB: RHHBY)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 240 |
Technical : | 216 |
Performance : | 213 |
Overall: | 269 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 239 |
Technical : | 188 |
Performance : | 187 |
Overall: | 253 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 237 |
Technical : | 230 |
Performance : | 236 |
Overall: | 282 |
Number of Stocks: | 306 |
Headlines
- Get Instant Biotech Diversification
Oct 22, 2009 01:09 PM | AMGN, BBI, GENZ, IMGN
- Emerging Market Or Pharma
Aug 25, 2009 02:57 PM | AZN, DNA, GOOG, GSK, NVS, RHHBY
- Safe(r) Ways To Play Biotech
Aug 18, 2009 09:57 AM | ABT, AMGN, GENZ, GILD, ISIS, NVS
- Screening For Solid Dividend Payers
Jun 12, 2009 01:28 PM | ACAS, ATNI, AZN, CHH, CMP, COL
- Access Pharma (OTC: ACCP.OB): A Cancer Biotech Call Option Trade
May 27, 2009 01:05 PM | CGRB, CTIC, DNDN, JNJ, RHHBY, SNY
- FDA, Clinical Trial Updates: BIIB, SLXP, CTIC, PFE, Roche (OTC:RHHBY)
May 20, 2009 11:31 AM | BIIB, CTIC, PFE, RHHBY, SLXP
- Drug Companies: A Powerhouse of Profits
May 08, 2009 02:11 PM | AZN, BMY, GSK, JNJ, LLY, MRK
- Healthcare, Is The Model Changing?
May 08, 2009 08:27 AM | CVD, GILD, KNDL, MRK, PFE, PPDI
- Swine Flu Pandemic Threatens Global Economic Recovery
Apr 28, 2009 07:56 AM | BAX, GILD, GSK, NVS, RHHBY, SNY
- Swine Flu Impact On Anti-Viral Sales
Apr 27, 2009 11:45 AM | GILD, GSK, RHHBY
- S.C. agencies face another $120 million in cuts: Budget is pared further amid state's 'startling' rate of unemployment
Nov 11, 2009 03:55 AM | RHHBY
- Trimeris Sued Ahead of Deal
Oct 31, 2009 07:51 AM | GS, RHHBY, TRMS
- Roche Deal Lifts SurModics Stock: Eden Prairie Firm Could Take in $200M
Oct 07, 2009 04:14 AM | DNA, JNJ, MRK, RHHBY, RX, SRDX
- Big Deals to Reshape Bay Area Biotech
Mar 12, 2009 08:51 PM | AFFY, CVTX, DNA, EXEL, GILD, JEF
- Big Deals Reshape Bay Area Biotech Industry
Mar 12, 2009 11:51 AM | AFFY, CVTX, DNA, EXEL, GILD, PFE
- Roche Increases Offer Price for Genentech
Mar 06, 2009 03:31 PM | DNA, RHHBY
- San Jose Mercury News, Calif., Chris O'Brien Column: O'Brien: Biotech Stays Steadier Than Most Sectors
Mar 06, 2009 12:53 PM | DNA, GILD, RHHBY
- Trimeris Reports Weaker Profit, Sales
Mar 03, 2009 05:52 PM | RHHBY, TRMS
- EDITORIAL: Optimism for a Pessimistic Time: It's Worth Remembering That the Seeds of the Region's Recovery Are Being Planted, and Some Already Are Taking Root.
Feb 07, 2009 05:53 PM | BMI, BP, BRC, BUCY, CAH, CSCO
- Drug Industry Flexes Muscles in New Jersey
Aug 19, 2008 02:06 PM | AG, DNA, JNJ, NOVN, NVS, RHHBY
- Roche and InterMune Initiate Phase 2b Clinical Trial of RG7227/ ITMN-191 in Patients With Chronic Hepatitis C
Aug 19, 2009 04:11 PM | ITMN, RHHBY
- Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
Apr 24, 2009 07:35 PM | RHHBY, VRUS
- Roche Completes Acquisition of Genentech
Mar 26, 2009 01:04 PM | DNA, RHHBY
- Roche Completes Tender Offer for Genentech
Mar 26, 2009 02:00 AM | DNA, RHHBY
- Roche Purchases Shares in Tender Offer For Memory Pharmaceuticals Corp.
Jan 02, 2009 08:01 AM | MEMY, RHHBY
- New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness
Nov 20, 2008 09:07 AM | RHHBY
- Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
Jul 21, 2008 12:34 AM | DNA, RHHBY
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
RHHBY
|
Compare to S&P
|
| YTD |
4.77 %
|
-13.29 %
|
| 4 Weeks |
0.63 %
|
-0.46 %
|
| 12 Weeks |
1.01 %
|
-4.77 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -0.01 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
